The challenge of long-term adherence: The role of bone turnover markers in monitoring bisphosphonate treatment of osteoporosis
- 28 March 2020
- journal article
- research article
- Published by Elsevier BV in Bone
- Vol. 136, 115336
- https://doi.org/10.1016/j.bone.2020.115336
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health Research
This publication has 86 references indexed in Scilit:
- BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronateJournal of Bone and Mineral Research, 2013
- European guidance for the diagnosis and management of osteoporosis in postmenopausal womenOsteoporosis International, 2012
- Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidenceJournal of Bone and Mineral Research, 2011
- A reappraisal of generic bisphosphonates in osteoporosisOsteoporosis International, 2011
- Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The NetherlandsOsteoporosis International, 2010
- Bisphosphonates: Mechanism of Action and Role in Clinical PracticeMayo Clinic Proceedings, 2008
- Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly womenBritish Journal of Clinical Pharmacology, 2008
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly WomenJournal of Bone and Mineral Research, 2004
- Response of Biochemical Markers of Bone Turnover to Hormone Replacement Therapy: Impact of Biological VariabilityJournal of Bone and Mineral Research, 1998